Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer

Autor: Yamaguchi, Rin, Tanaka, Maki, Yano, Ayako, Tse, Gary M., Yamaguchi, Miki, Koura, Keiko, Kanomata, Naoki, Kawaguchi, Atsushi, Akiba, Jun, Naito, Yoshiki, Ohshima, Koichi, Yano, Hirohisa

Publikováno v: In Human Pathology October 2012 43(10):1688-1694

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis.

Autor: Takenaka M; Departments of Pathology, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ; ; Surgery, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ;, Seki N; Research Center for Innovative Cancer Therapy, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ;, Toh U; Surgery, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ;, Hattori S; Biostatistical Center, Kurume University, Kurume, Fukuoka 830-0011, Japan ;, Kawahara A; Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Fukuoka 830-0011, Japan ;, Yamaguchi T; Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Fukuoka 830-0011, Japan ;, Koura K; Departments of Pathology, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ; ; Surgery, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ;, Takahashi R; Surgery, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ;, Otsuka H; Surgery, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ;, Takahashi H; Surgery, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ;, Iwakuma N; Surgery, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ;, Nakagawa S; Surgery, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ;, Fujii T; Surgery, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ; ; Multidisciplinary Treatment Center, Kurume University Hospital, Kurume, Fukuoka 830-0011, Japan ;, Sasada T; Department of Immunology, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan., Yamaguchi R; Departments of Pathology, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ;, Yano H; Departments of Pathology, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ;, Shirouzu K; Surgery, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ;, Kage M; Research Center for Innovative Cancer Therapy, School of Medicine, Kurume University, Kurume, Fukuoka 830-0011, Japan ; ; Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Fukuoka 830-0011, Japan ;

Publikováno v: Molecular and clinical oncology [Mol Clin Oncol] 2013 Jul; Vol. 1 (4), pp. 625-632. Date of Electronic Publication: 2013 Apr 26.